dMed

Acquired
Total Funding
$200.0M
Last Round
$50.0M Series CJul 2021
Rounds
5

About

Leading Chinese specialty clinical development CRO (exited)

Summary

It has raised $200.0M in total across 5 rounds, most recently a $50.0M Series C round in Jul 2021. Investors include Fidelity Management, Qiming VP and Lilly Asia Ventures.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series CSeries CJul 2021
$50.0M

Sign up to see all 5 rounds

Full funding history, per-round amounts, and investor participation.

Investors